Influence of FuZheng KangLiu Prescription on Life Quality and Cellular Immunity of Lung Cancer Patients Undergoing Chemotherapy

Objective: To observe the influence of FuZheng KangLiu prescription on cellular immunity and life quality of lung cancer patients undergoing chemotherapy. Methods: Eighty-five patients were randomized into the treatment group(40 cases) and the control group(45 cases), both groups received routine chemotherapy, the treatment group were given with self-design FuZheng KangLiu prescription, the changes of T-lymphocyte subsets(CD4+/CD8+in peripheral venous blood) were detected before treating and in ten days after treating; the changes of life quality in both groups observed in 16 weeks after treating. Results: CD4+, CD8+, CD4+/CD8+in both groups were improved after treating(P0.05), the improvement of the treatment group was more notable(P0.05). Somatic function and total health scores in the treatment group were ameliorated notably after treating(P0.05), the difference was significant compared with the control group(P0.05). Conclusion: FuZheng KangLiu prescription in intervening venous chemotherapy of lung cancer patients could raise immunity of the patients in short-term and improve long-term life quality of the patients.